Targeting mTOR as a novel therapeutic strategy for traumatic CNS injuries.
Targeting mTOR as a novel therapeutic strategy for traumatic CNS injuries.
复制标题
DOI:
10.1016/j.drudis.2012.04.010
复制
发表时间:
2012-08
影响因子:
7.4
通讯作者:
Zheng, X. F. Steven
中科院分区:
文献类型:
--
作者:
Don, Aruni S. Arachchige;Tsang, Chi Kwan;Kazdoba, Tatiana M.;D'Arcangelo, Gabriella;Young, Wise;Zheng, X. F. Steven
The adult central nervous system (CNS) has a remarkable ability to repair itself. However, severe brain and spinal cord injuries cause lasting disability and there are only a few therapies that can prevent or restore function in such cases. In this review, we provide an overview of traumatic CNS injuries and discuss several emerging pharmacological options that have shown promise in preclinical and early clinical studies. We highlight therapies that modulate mammalian target of rapamycin (mTOR) signaling, a pathway that is well known for its roles in cell growth, metabolism and cancer. Interestingly, this pathway is also gaining newfound attention for its role in CNS repair and regeneration.
登录
查看更多内容
影响因子:
3.5
作者:
Han, Jin;Wang, Bin;Dai, Jianwu
通讯作者:
Dai, Jianwu
影响因子:
6.1
作者:
Erlich, S.;Alexandrovich, A.;Pinkas-Kramarski, R.
通讯作者:
Pinkas-Kramarski, R.
影响因子:
4.3
作者:
Ljungberg, M. Cecilia;Sunnen, C. Nicole;D'Arcangelo, Gabriella
通讯作者:
D'Arcangelo, Gabriella
影响因子:
5.3
作者:
Jossin, Yves;Gui, Lanrun;Goffinet, Andre M.
通讯作者:
Goffinet, Andre M.
影响因子:
2.1
作者:
MARTEL, RR;KLICIUS, J;GALET, S
通讯作者:
GALET, S